Advancing Menopause Care Act

Full Title:
Advancing Menopause Care and Mid-Life Women’s Health Act

Summary#

This bill would create new Federal activities to study and address perimenopause, menopause, and postmenopause and related mid-life women’s health issues. It directs the National Institutes of Health (NIH) and the Department of Health and Human Services (HHS) to expand and coordinate research, to add categories in NIH research tracking, and to award grants for research and training. The bill also requires public health promotion, an awareness and education website, training programs for clinicians, Centers of Excellence, a public dashboard, annual reports to Congress, and coordination with other Federal agencies. The bill lists specific symptoms and conditions to be studied (for example, vasomotor symptoms, osteoporosis, mental health, cardiovascular conditions, sleep disorders, pelvic floor disorders, and others) and identifies many kinds of eligible grant recipients, such as medical and nursing schools, teaching hospitals, research institutions, behavioral health clinics, and small businesses.

What it means for you#

  • Patients and caregivers: The bill would direct HHS to create national education materials and an online resource about perimenopause and menopause. It would support outreach that can be tailored by State, local, Tribal, and territorial public health departments.
  • Health care providers and students: The bill would fund training programs, continuing education, and Centers of Excellence to expand clinical knowledge about menopausal symptoms and related conditions. Providers could have new tools, best-practice recommendations, and training opportunities.
  • Health and research organizations: Eligible entities could apply for grants to do biomedical and public health research, develop diagnostics and treatments, test integrated care models, run training programs, or be designated as Centers of Excellence.
  • Employers and workplaces: The bill directs research on workplace stressors related to severe menopausal symptoms and asks HHS to develop recommendations, but it does not itself change workplace rules or benefits.

Expenses#

  • NIH and HHS research activities (sections 404P and 310C): authorized $25,000,000 for each fiscal year 2027 through 2031.
  • Public health promotion activities (section 399PP): authorized $10,000,000 for each fiscal year 2027 through 2031.
  • Public awareness, education, and outreach program (section 399PP-1): authorized $10,000,000 for each fiscal year 2027 through 2031.
  • Training programs to improve care and treatment (section 758): authorized $10,000,000 for each fiscal year 2027 through 2031.
  • Centers of Excellence (section 399PP-2) and the reporting requirement (section 7): authorized "such sums as may be necessary" for each of fiscal years 2027 through 2031.
  • No additional cost estimates or budget impacts are included in the bill text provided.

Proponents' View#

The bill describes its purpose as improving menopause care and mid-life women’s health by expanding research, public health promotion, provider training, awareness, and care coordination. It would increase Federal grants and programs to study symptoms and long-term effects, develop and test treatments and care models, create education materials and online resources, and establish Centers of Excellence to spread evidence-based information.

Opponents' View#

No publicly available information.